FLGT Q2 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q2 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$82M+15.2% YoY

Gross Profit

$34M42.1% margin

Operating Income

-$20M-24.1% margin

Net Income

-$19M-23.2% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$37M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$88M

Stockholders' Equity

$1.1B

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$71M	+15.2%
Gross Profit	$34M	$26M	+30.0%
Operating Income	-$20M	-$19M	-4.3%
Net Income	-$19M	-$9M	-117.6%

Revenue Segments

Laboratory Services

$82M100%

Geographic Segments

UNITED STATES

$76M87%

Non-US

$6M6%

Other Countries

$3M4%

CHINA

$2M3%